Latest Fluicell News & Updates

See the latest news and media coverage for Fluicell. We track all announcements, press releases, and industry mentions in real time, all in one place.

Fluicell

Tissue engineering company for regenerative medicine and drug screening

fluicell.com

Headquarters: Mölndal, Sweden
Founded year: 2012
Company type: Public company
Number of employees: 10–17
Industry: Pharmaceuticals

Last updated September 15

Latest news about Fluicell

In short: Fluicell posted record first-half revenue, secured an Ambusol license, and advanced diabetes and bioprinting programs.

Company announcements

August 28 Fluicell

Fluicell releases a half-year report for the period January to June 2026

The company reports record-high revenues and earnings per share of 4.05 SEK during the first half of 2026. Successful trials with the diabetes project are noted.

May 8 Fluicell

Fluicell publishes interim report for Q1 2026

Net sales increase to 6.1 MSEK, 26 times higher than the previous year. EBITDA becomes positive at 3.4 MSEK. Patent granted in the EU.

April 8 Fluicell

Fluicell publishes annual report for 2025

The annual report is available on the Company's website and as an attached file. For more information, contact the CEO or CFO.

February 20 Fluicell

Fluicell publishes year-end report for 2025

Net sales Q4 increased 645% to 3.8 MSEK with positive cash flow after investments. Year's net sales 6 MSEK. Strong finish to 2025.

Media coverage

September 15 Zone Bourse

Fluicell: settlement of a customer claim of 6 million crowns

The biotechnology company Fluicell has received full payment of a customer claim previously mentioned in its half-year report, according to a press release. The...

August 28 Zone Bourse

Fluicell increases its revenue and returns to operating profit

The life sciences company Fluicell reports higher revenue in the second quarter compared to the same period last year...

May 8 Dagens industri

Fluicell turned to profit in the first quarter

Fluicell reports an operating result of 3.3 million kronor (-2.6) in the first quarter of 2026. Sales increased to 6.1 million kronor (0.2) with revenues of 8.4...

February 20 Dagens industri

Fluicell increases sales - reduces loss

The medical technology company Fluicell reports an operating result of -0.1 million kronor (-1.8) for the fourth quarter of 2025.

Never miss news about Fluicell

Track Fluicell and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Fluicell competitors & trending companies

Browse news for competitors to Fluicell and other trending companies.